Hydroxychloroquine and azithromycin to treat COVID-19 clinical trial begins

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded [...]

The post Hydroxychloroquine and azithromycin to treat COVID-19 clinical trial begins appeared first on Outbreak News Today.